LMAT - LEMAITRE VASCULAR INC

QQQ $ 598.33 $ 0.00 (0 %)

DIA $ 462.05 $ 0.00 (0 %)

SPY $ 661.93 $ 0.00 (0 %)

TLT $ 89.19 $ 0.00 (0 %)

GLD $ 377.43 $ 0.00 (0 %)

Previous Close

$ 86.48

Open

$ 86.73

Bid

$ 83.67 x 1

Ask

$ 100.00 x 6

Day's Range

-- - --

52 Week Range

$ 71.10 - $ 108.82

Volume

153,671

Average Volume

Market Cap

1.96B

Beta (5Y Monthly)

$ 0.65

PE Ratio (TTM)

$ 36.78

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-07-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-08-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	02-29-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-01-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-05-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-10-2021	03-31-2021	10-Q
20	03-12-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	03-12-2020	12-31-2019	10-K
25	11-08-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-06-2019	03-31-2019	10-Q
28	03-11-2019	12-31-2018	10-K
29	11-02-2018	09-30-2018	10-Q
30	08-06-2018	06-30-2018	10-Q
31	05-04-2018	03-31-2018	10-Q
32	03-09-2018	12-31-2017	10-K
33	11-03-2017	09-30-2017	10-Q
34	08-03-2017	06-30-2017	10-Q
35	05-04-2017	03-31-2017	10-Q
36	03-09-2017	12-31-2016	10-K
37	11-04-2016	09-30-2016	10-Q
38	08-05-2016	06-30-2016	10-Q
39	05-06-2016	03-31-2016	10-Q
40	03-10-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Maintains Equal-Weight on LeMa...
11/07/2025 18:55:37

Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price targe...

LeMaitre Vascular Raises FY2025 GAAP EPS G...
11/06/2025 21:07:58

LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.23-$2.37 to $2.48-$2.53 vs $2.27 analyst estimate. Lowe...

LeMaitre Vascular Sees Q4 GAAP EPS $0.64-$...
11/06/2025 21:07:29

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q4 GAAP EPS of $0.64-$0.69 vs $0.63 analyst estimate. sees sales of $61.800 mill...

LeMaitre Vascular Q3 EPS $0.75 Beats $0.57...
11/06/2025 21:05:46

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0....

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Roth Capital Reinstates Buy on LeMaitre Va...
11/05/2025 17:29:34

Roth Capital analyst Kyle Bauser reinstates LeMaitre Vascular (NASDAQ:LMAT) with a Buy and announces $108 price target.

Where LeMaitre Vascular Stands With Analysts
10/15/2025 12:00:51

Barrington Research Maintains Outperform o...
10/15/2025 11:49:11

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 pr...

Barrington Research Maintains Outperform o...
09/23/2025 15:15:36

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 pr...

Cantor Fitzgerald Maintains Neutral on LeM...
08/06/2025 14:03:06

Cantor Fitzgerald analyst Ross Osborn maintains LeMaitre Vascular (NASDAQ:LMAT) with a Neutral and raises the price target f...

Barrington Research Upgrades LeMaitre Vasc...
08/06/2025 13:06:36

Barrington Research analyst Michael Petusky upgrades LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Outperform and a...

LeMaitre Vascular Sees Q3 GAAP EPS $0.54-$...
08/05/2025 20:23:31

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q3 GAAP EPS of $0.54-$0.59 vs $0.54 analyst estimate. sees sales of $61.200 mill...

LeMaitre Vascular Raises FY2025 GAAP EPS G...
08/05/2025 20:23:19

LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.07-$2.24 to $2.23-$2.37 vs $2.15 analyst estimate. Rais...

LeMaitre Vascular Q2 EPS $0.60 Beats $0.57...
08/05/2025 20:08:22

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0....

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Barrington Research Reiterates Market Perf...
07/22/2025 14:27:30

Barrington Research analyst Michael Petusky reiterates LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Market Perform.

LeMaitre Vascular Lowers FY2025 GAAP EPS G...
05/01/2025 20:14:05

LeMaitre Vascular (NASDAQ:LMAT) lowers FY2025 GAAP EPS guidance from $2.15-$2.32 to $2.07-$2.24 vs $2.24 analyst estimate. Rais...

LeMaitre Vascular Sees Q2 GAAP EPS $0.55-$...
05/01/2025 20:13:56

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q2 GAAP EPS of $0.55-$0.59 vs $0.58 analyst estimate. sees sales of $61.500 mill...

LeMaitre Vascular Q1 EPS $0.48 Misses $0.5...
05/01/2025 20:08:04

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.48 per share which missed the analyst consensus estimate of $...

Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37